Pronounced induction of CYP4A, CYP2B and CYP3A activity in rats treated with the RXR agonists RWJ-392063 and RWJ-666589

被引：0
|
作者：
Krueger, Linda A.
McMullen, Maggie
Parkinson, Andrew
Stahle, Paul
Streeter, Anthony J.
机构：
[1] XenoTech LLC, Lenexa, KS USA
[2] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
168
引用
收藏
页码：107 / 107
页数：1
相关论文
共 30 条
  • [21] Use of a quantitative real-time reverse transcription-polymerase chain reaction method to study the induction of CYP1A, CYP2B and CYP4A forms in precision-cut rat liver slices
    Pan, J
    Xiang, Q
    Renwick, AB
    Price, RJ
    Ball, SE
    Kao, J
    Scatina, JA
    Lake, BG
    XENOBIOTICA, 2002, 32 (09) : 739 - 747
  • [22] Species-specific induction of CYP2B by 2,4,6-tryphenyldioxane-1,3 (TPD)
    Pustylnyak, Vladimir
    Pivovarova, Elena
    Slynko, Nikolai
    Gulyaeva, Lyudmila
    Lyakhovich, Vyacheslav
    LIFE SCIENCES, 2009, 85 (23-26) : 815 - 821
  • [23] Effect of several analogs of 2,4,6-triphenyldioxane-1,3 on CYP2B induction in mouse liver
    Pustylnyak, Vladimir
    Kazakova, Yuliya
    Yarushkin, Andrei
    Slynko, Nikolai
    Gulyaeva, Lyudmila
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 194 (2-3) : 134 - 138
  • [24] Quantitative structure-activity relationships within a homologous series of 7-alkoxyresorufins exhibiting activity towards CYP1A and CYP2B enzymes: molecular modelling studies on key members of the resorufin series with CYP2C5-derived models of human CYP1A1, CYP1A2, CYP2B6 and CYP3A4
    Lewis, DFV
    Lake, BG
    Dickins, M
    XENOBIOTICA, 2004, 34 (06) : 501 - 513
  • [25] The relationship between mrna and activity following induction of CYP3A4 and CYP2B6 across a range of prototypical inducers
    Almond, Lisa
    Tay, Suzanne
    Wong, Susan
    Mukadam, Sophie
    Gardner, Iain
    Rowland-Yeo, Karen
    Kenny, Jane
    DRUG METABOLISM REVIEWS, 2016, 48 : 86 - 86
  • [26] Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2
    Rhodes, Susan P.
    Otten, Jennifer N.
    Hingorani, Gary P.
    Hartley, Dylan P.
    Franklin, Ronald B.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 63 (03) : 223 - 226
  • [27] Minor changes in 2,4,6-tryphenyldioxane-1,3 inducer structure cause changes in CAR mediated CYP2B induction
    Pustylnyak, Vladimir
    Yarushkin, Andrey
    Kachaylo, Ekaterina
    Slynko, Nikolay
    Gulyaeva, Lyudmila F.
    DRUG METABOLISM REVIEWS, 2010, 42 : 158 - 158
  • [28] Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B
    Diwan, BA
    Henneman, JR
    Rice, JM
    Nims, RW
    CARCINOGENESIS, 1996, 17 (01) : 37 - 43
  • [29] COMPARATIVE PHARMACODYNAMICS OF HEPATIC CYP2B INDUCTION IN MALE B6C3F1 MICE AND F344/NCR RATS EXPOSED TO PHENOBARBITAL OR TCPOBOP
    NIMS, RW
    BEEBE, LE
    MELLINI, DW
    UTERMAHLEN, WE
    THOMAS, PE
    LUBET, RA
    FASEB JOURNAL, 1994, 8 (07): : A1246 - A1246
  • [30] An in-vitro validation study in the field of toxicokinetics and metabolism: Validation of an LC-MS/MS assay for simultaneous assessment of cytochrome P450 activity using cryopreserved human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, CYP2C9 and CYP1A2
    Bourgogne, E.
    Saucez, G.
    Dell'Aiera, S.
    Rosa, M.
    Jacques-hespel, C.
    Gerin, B.
    Chanteux, H.
    Nicolas, J. M.
    TOXICOLOGY LETTERS, 2011, 205 : S153 - S153
123